Enhancing Recognition of Late‐Onset Pompe Disease to Facilitate Personalized, Multidisciplinary Care and Maintain Function: The Promise of Emerging Agents
Released On
October 26, 2022
Expires On
October 26, 2023
Media Type
Internet
Completion Time
60 minutes
Specialty
Neurology, Internal Medicine, Primary Care, Pediatrics, Pharmacy
Topic(s)
Neurology, Pompe disease
Scroll to the Bottom of this Information to Begin this Course
This activity is jointly provided by Global Education Group and PlatformQ Health Education, LLC.
In collaboration with the National Organization for Rare Disorders, Inc (NORD).
This activity is supported by an educational grant from Amicus Therapeutics Inc.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
All other health care professionals completing this course will be issued a statement of participation.
Target Audience
The educational design of this activity addresses the needs of neurologists (adult and pediatric), internal medicine physicians, primary care physicians, pediatricians, pharmacists, neurology advanced practice providers and nurses, and other clinicians who care for patients with LOPD.
Program Overview
Patients with late‐onset Pompe disease (LOPD) often experience significant diagnostic delays and are susceptible to potential misdiagnoses. In addition, current treatments are associated with a number of limitations, leading to investigations of new agents that may offer greater safety, tolerability, and efficacy.
Join Dr. Loren Peña to review the symptoms of LOPD, patient factors that might influence care, and advances in the management of LOPD. Dr. Peña will discuss how to effectively incorporate new treatments, when available, into daily clinical practice and differentiate current and emerging agents to determine their appropriate place in the care of LOPD. Clinicians will be prepared to engage their patients in effective shared decision-marking to develop care plans that address the needs of their patients with LOPD.
Learning Objectives
After completing this activity, the participant should be better able to:
- Recognize signs and symptoms that may raise the index of suspicion for LOPD
- Identify strategies and emerging agents to address limitations of current treatment options for LOPD
- Assess the comparative safety, efficacy, and tolerability profiles and therapeutic potential of agents being investigated for the treatment of LOPD
- Discuss the importance of engaging patients with LOPD via shared decision‐making and how it could impact outcomes
Faculty
Loren D.M. Peña, MD, PhD
Associate Professor of Pediatrics
Cincinnati Children’s Hospital
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and PlatformQ Health Education, LLC. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point(s) in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Disclosures of Conflicts of Interest
Global Education Group (Global) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
| Name of Faculty or Presenter | Reported Financial Relationship |
|---|---|
| Loren D.M. Peña, MD, PhD Associate Professor of Pediatrics Cincinnati Children’s Hospital President, Cleveland Clinic Martin Hospital |
Nothing to disclose. |
The planners and managers have the following relevant financial relationships with ineligible companies:
| Name of Planner or Manager | Reported Financial Relationship |
|---|---|
| Lindsay Borvansky | Nothing to disclose |
| Andrea Funk | Nothing to disclose |
| Liddy Knight | Nothing to disclose |
| Ashley Cann | Nothing to disclose |
| Lauren Sinclair | Nothing to disclose |
| Colleen Heffner | Nothing to disclose |
| Carole Drexel | Nothing to disclose |
| Alissa Yost | Nothing to disclose |
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PlatformQ Health Education, LLC do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Instructions to Receive Credit
In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a score of 70% on the post-test.
Fee Information & Refund/Cancellation Policy
There is no fee for this educational activity.
Hardware/Software Requirements
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Contact Information
Accreditation Support:
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.
Technical Support:
For any technical issues or issues with your CME Certificate, please contact NeuroSeriesLive at 877-394-1306 or at Support@NeuroSeriesLive.com.
PlatformQ Health Privacy Policy:
By clicking “Start Activity” you are agreeing to PlatformQ Health’s privacy policy. PlatformQ Health takes your privacy very seriously. The full Privacy Policy found here describes (i) the types of information we collect from you when you visit our Site; (ii) how we use the information we collect; (iii) with whom and why we share it; and (iv) the choices we offer regarding our use of the information. We also describe how to contact us about our privacy practices.
Information we collect is primarily used to communicate with program participants, award CME/CE credits, manage user accounts, recommend relevant programs and perform data analysis to inform educational outcomes.
In plain English, here is what we affirm:
- You can change your registration profile at any time from our “Profile” page
- To request any of these changes without logging in, please call us at 1 (877) 394-1306 or email us at support@PlatformQHealth.com
- You can end your association with PlatformQ Health at any time
- PlatformQ Health does not spam, nor we do we rent or sell our email list in whole or in part. Any program-related data sharing is for engagement verification and opt-in based further education
- EU citizens can request a complete record of their account and/or request to have their personal data expunged by contacting support@PlatformQHealth.com with the subject line “Data Request”
You acknowledge and agree that by beginning this activity, you have affirmatively agreed to this Privacy Policy and consented to receiving electronic messages in conformance with this Privacy Policy. Please read the full privacy policy located at: www.platformqhealth.com/privacy-policy/